Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: A medical chart review across ten centers in five European countries

1. Porta, C.
2. Levy, A.
3. Hawkins, R.
4. Castellano, D.
5. Bellmunt, J.
6. Nathan, P.
7. Mcdermott, R.
8. Wagstaff, J.
9. Donnellan, P.
10. Mccaffrey, J.
11. Vekeman, F.
12. Neary, M.P.
13. Diaz, J.
14. Mehmud, F.
15. Duh, M.S.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1002/CAM4.302 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus